zn-c5
Small moleculeexperimental
Clinical trial activity
5 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2018 (NCT03560531)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Estrogen receptorINHIBITOR
Estrogen receptor inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04852419 | Phase 1 | May 31, 2021 | Zentera Therapeutics HK Limited |
| NCT04514159 | Phase 1 | Nov 30, 2020 | Zeno Pharmaceuticals |
| NCT04561752 | Phase 1 | Nov 2, 2020 | Zeno Pharmaceuticals |
| NCT04176757 | Phase 1 | Dec 31, 2019 | Zeno Pharmaceuticals |
| NCT03560531 | Phase 1 | Jun 30, 2018 | Zeno Pharmaceuticals |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zeno Pharmaceuticals | For profit | 4 | 4 | 1 | 2018 |
| Zentera Therapeutics HK Limited | For profit | 1 | 1 | 1 | 2021 |
2 organizations
Page 1 / 1